{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:40:03Z","timestamp":1791416403456,"version":"4.3.3"},"reference-count":12,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2006,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Streptococcus pseudopneumoniae<\/jats:italic>\n                    is a recently described streptococcus that is phenotypically and genetically distinct from\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    and other viridans streptococci. Key characteristics of\n                    <jats:italic>S. pseudopneumoniae<\/jats:italic>\n                    are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO\n                    <jats:sub>2<\/jats:sub>\n                    but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of\n                    <jats:italic>S. pseudopneumoniae<\/jats:italic>\n                    isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW\n                    <jats:italic>S. pneumoniae<\/jats:italic>\n                    antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    isolated from sputum, patients with\n                    <jats:italic>S. pseudopneumoniae<\/jats:italic>\n                    infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of\n                    <jats:italic>S. pseudopneumoniae<\/jats:italic>\n                    colonization and the role of\n                    <jats:italic>S. pseudopneumoniae<\/jats:italic>\n                    in COPD and other diseases.\n                  <\/jats:p>","DOI":"10.1128\/jcm.44.3.923-927.2006","type":"journal-article","created":{"date-parts":[[2006,3,3]],"date-time":"2006-03-03T17:28:19Z","timestamp":1141406899000},"page":"923-927","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["Characteristics of\n                    <i>Streptococcus pseudopneumoniae<\/i>\n                    Isolated from Purulent Sputum Samples"],"prefix":"10.1128","volume":"44","author":[{"given":"Elaine R.","family":"Keith","sequence":"first","affiliation":[{"name":"Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslyn G.","family":"Podmore","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor P.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Murdoch","sequence":"additional","affiliation":[{"name":"Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand"},{"name":"Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4686-4696.2004"},{"key":"e_1_3_2_3_2","unstructured":"Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. CLSI Wayne Pa."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.4999-5006.2005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.174.17.5508-5515.1992"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/ijs.0.63577-0"},{"key":"e_1_3_2_7_2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. 2004. Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO workshop report. National Heart Lung and Blood Institute National Institutes of Health Bethesda Md."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.1.63-66.2003"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.5.2271.2003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2545-2554.2002"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1513\/pats.2306029"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012561"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1374-1382.2000"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.44.3.923-927.2006","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.44.3.923-927.2006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:54:49Z","timestamp":1646438089000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.44.3.923-927.2006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["10.1128\/JCM.44.3.923-927.2006"],"URL":"https:\/\/doi.org\/10.1128\/jcm.44.3.923-927.2006","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1031585.368752","asserted-by":"object"}]},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"2005-10-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-12-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2006-03-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}